OTCMKTS:BMXMF - BioMerieux Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$75.31 -0.19 (-0.25 %)
(As of 11/18/2018 11:16 AM ET)
Previous Close$75.31
Today's Range$74.7250 - $75.31
52-Week Range$72.51 - $96.25
Volume106 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
bioMérieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc. It also provides molecular biology for the detection of genetic sequences of deoxyribonucleic acid or ribonucleic acid; and companion diagnostic test based on biomarkers, as well as services for clinical and industrial laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is based in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Receive BMXMF News and Ratings via Email

Sign-up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Previous Symbol


Debt-to-Equity Ratio0.22
Current Ratio1.99
Quick Ratio1.30


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.58 billion
Price / Sales3.45
Cash FlowN/A
Price / CashN/A
Book Value$16.58 per share
Price / Book4.54


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares118,360,000
Market Cap$0.00
OptionableNot Optionable

BioMerieux (OTCMKTS:BMXMF) Frequently Asked Questions

What is BioMerieux's stock symbol?

BioMerieux trades on the OTCMKTS under the ticker symbol "BMXMF."

Has BioMerieux been receiving favorable news coverage?

Headlines about BMXMF stock have trended somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. BioMerieux earned a news sentiment score of 1.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future.

Who are some of BioMerieux's key competitors?

Who are BioMerieux's key executives?

BioMerieux's management team includes the folowing people:
  • Mr. Alexandre Mérieux, Chairman & CEO (Age 44)
  • Mr. Guillaume Bouhours, Exec. VP & CFO (Age 42)
  • Sylvain Morgeau, Investor Relations
  • Mr. Michel Baguenault, Exec. VP of HR & Communications and Company Sec.
  • Ms. Claire Giraut, Chief Financial Officer and Corp. VP (Age 62)

How do I buy shares of BioMerieux?

Shares of BMXMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioMerieux's stock price today?

One share of BMXMF stock can currently be purchased for approximately $75.31.

What is BioMerieux's official website?

The official website for BioMerieux is http://www.biomerieux.com.

How can I contact BioMerieux?

BioMerieux's mailing address is 376 CHEMIN DE L`ORME, MARCY L`ETOILE I0, 69280. The company can be reached via phone at 33-4-78-87-20-00 or via email at [email protected]

MarketBeat Community Rating for BioMerieux (OTCMKTS BMXMF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  108
MarketBeat's community ratings are surveys of what our community members think about BioMerieux and other stocks. Vote "Outperform" if you believe BMXMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMXMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2018 by MarketBeat.com Staff

Featured Article: Cash Flow

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel